Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T
暂无分享,去创建一个
A. Celler | A. Rahmim | S. Ziegler | G. Böning | P. Bartenstein | F. Gildehaus | A. Gosewisch | H. Ilhan | A. Todica | C. Uribe | L. Kaiser | J. Brosch-Lenz | P. Bartenstein